Company Quick10K Filing
OWC Pharmaceutical Research
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-13
S-1 2019-05-31 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-16
S-1 2018-06-14 Public Filing
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-18
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-29
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-17
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-01
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-21
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-04-15
8-K 2020-09-23
8-K 2020-09-14
8-K 2020-08-31
8-K 2020-06-25
8-K 2020-06-21
8-K 2020-03-30
8-K 2020-03-19
8-K 2020-03-12
8-K 2020-03-09
8-K 2019-12-20
8-K 2019-12-12
8-K 2019-11-13
8-K 2019-11-13
8-K 2019-10-22
8-K 2019-10-07
8-K 2019-09-16
8-K 2019-08-29
8-K 2019-07-24
8-K 2019-05-23
8-K 2019-05-06
8-K 2019-04-15
8-K 2019-04-04
8-K 2019-03-13
8-K 2019-02-22
8-K 2019-02-05
8-K 2019-02-01
8-K 2019-01-29
8-K 2018-12-31
8-K 2018-11-30
8-K 2018-11-30
8-K 2018-10-22
8-K 2018-08-21
8-K 2018-08-01
8-K 2018-06-28
8-K 2018-06-13
8-K 2018-04-30
8-K 2018-03-08
8-K 2018-03-05
8-K 2018-02-19

OWC Pharmaceutical Research Financials

OWCP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
024 Pharma (EEIG)

Balance Sheet ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4178298471,3891,4691,166799532357266162904721,3801,1139716924,6494,2193,4642,8001,8401,465
Accounts Receivable
Inventory
PP&E26292928262318371411104633333373353331
Assets4178298471,4371,5231,1958405684303432391304972,0761,4131,2181,0617364,7744,3123,5532,9492,3351,773
Accounts Payable12173753459853640657112823198163104286
Long-Term Debt
Liabilities741021284981604056471083153512373964481762082702346,4246,76810,76710,2511,7501,467
Stockholders' Equity-57-947981,3561,4631,15478552132328-150-1071011,6271,2371,010791502-2,183-3,791-9,440-10,242-3,043-4,008
Income Statement ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000050000010001000
Cost of Revenue
Gross Profit
R&D0000000160997797-15373530-2443421694-782155273126285320168
SG&A59149149472-1074,3541543055333112452228475-2,3871,4011,5581,106-6,851821756543498395519
Tax0000000000
Net Income-71-170-42-35-509-4,354-315-405-408-233-314-80-141-1,658-1,435-445-1,201-1,477-977-2,990-991-1,0007,707-287
Cash Flow ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-19-49-14-9-17-22-289-274-3871,138-1,795-173-172-100-126-131-191-395-274-326-371-949-427-665-955-372
Cash Investing-6-2-2010-10-2-6-10-10-20-20
Cash Financing156354238608593539002410710505251,768-273101891054,9180000